Minna Roh-Johnson

Minna Roh-Johnson

Auto-generated profile, based on publicly available information

Minna Roh-Johnson

Department of Biochemistry, University of Utah

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2023 in eLife
Verified
Journal Article
Open access
CKChelsea U Kidwell
Chelsea U Kidwell
JCJoseph Raymond Casalini
Joseph Raymond Casalini
SPSoorya Pradeep
Soorya Pradeep
SSSandra Daniela Scherer
Sandra Daniela Scherer
DGDaniel Greiner
Daniel Greiner
MRMinna Roh-Johnson
Minna Roh-Johnson
Recent studies reveal that lateral mitochondrial transfer, the movement of mitochondria from one cell to another, can affect cellular and tissue homeostasis. Most of what we know about mitochondrial transfer stems from bulk cell studies and have led to the paradigm that functional transferred mitochondria restore bioenergetics and revitalize cellular functions to recipient cells with damaged or non-functional mitochondrial networks. However, we show that mitochondrial transfer also occurs between cells with functioning endogenous mitochondrial networks, but the mechanisms underlying how transferred mitochondria can promote such sustained behavioral reprogramming remain unclear. We report that unexpectedly, transferred macrophage mitochondria are dysfunctional and accumulate reactive oxygen species in recipient cancer cells. We further discovered that reactive oxygen species accumulation activates ERK signaling, promoting cancer cell proliferation. Pro-tumorigenic macrophages exhibit fragmented mitochondrial networks, leading to higher rates of mitochondrial transfer to cancer cells. Finally, we observe that macrophage mitochondrial transfer promotes tumor cell proliferation in vivo. Collectively these results indicate that transferred macrophage mitochondria activate downstream signaling pathways in a ROS-dependent manner in cancer cells, and provide a model of how sustained behavioral reprogramming can be mediated by a relatively small amount of transferred mitochondria in vitro and in vivo.

5 August 2021 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
ENEsther Nuebel
Esther Nuebel
JMJeffrey T Morgan
Jeffrey T Morgan
SFSarah Fogarty
Sarah Fogarty
JWJacob M Winter
Jacob M Winter
SLSandra Lettlova
Sandra Lettlova
JRJared Rutter
Jared Rutter

13 March 2025 in Oncogene
Verified
Journal Article
Open access
PDF file
DGDaniel Greiner
Daniel Greiner
QXQian Xue
Qian Xue
TWTrinity Qa Waddell
Trinity Qa Waddell
EKElena Kurudza
Elena Kurudza
PCPiyush Chaudhary
Piyush Chaudhary
MRMinna Roh-Johnson
Minna Roh-Johnson
Approximately half of melanoma patients relapse or fail to respond to current standards of care, highlighting the need for new treatment options. Engineering T-cells with chimeric antigen receptors (CARs) has revolutionized the treatment of hematological malignancies but has been clinically less effective in solid tumors. We therefore sought to engineer alternative immune cell types to inhibit melanoma progression. Engineering macrophages with CARs has emerged as a promising approach to overcome some of the challenges faced by CAR-T cells; however, whether these engineered macrophages can effectively inhibit melanoma growth is unknown. To determine whether CAR-macrophages (CAR-Ms) specifically target and kill melanoma cells, we engineered CAR-Ms targeting chondroitin sulfate proteoglycan 4 (CSPG4), an antigen expressed in melanoma. CSPG4-targeting CAR-Ms exhibited specific phagocytosis of CSPG4-expressing melanoma cells. We developed 3D approaches to show that CSPG4-targeting CAR-Ms efficiently infiltrated melanoma spheroids. Furthermore, combining CSPG4-targeting CAR-Ms with strategies inhibiting CD47/SIRPα “don’t eat me” signaling synergistically enhanced CAR-M-mediated phagocytosis and robustly inhibited melanoma spheroid growth in 3D. Importantly, CSPG4-targeting CAR-Ms inhibited melanoma tumor growth in mouse models. These results suggest engineering macrophages against melanoma antigens is a promising solid tumor immunotherapy approach for treating melanoma.

25 August 2022 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
JMJulio C. Fierro Morales
Julio C. Fierro Morales
QXQian Xue
Qian Xue
MRMinna Roh-Johnson
Minna Roh-Johnson
Cell-substrate adhesion is a critical aspect of many forms of cell migration. Cell adhesion to an extracellular matrix (ECM) generates traction forces necessary for efficient migration. One of the most well-studied structures cells use to adhere to the ECM is focal adhesions, which are composed of a multilayered protein complex physically linking the ECM to the intracellular actin cytoskeleton. Much of our understanding of focal adhesions, however, is primarily derived fromin vitrostudies in Metazoan systems. Though these studies provide a valuable foundation to the cell-substrate adhesion field, the evolution of cell-substrate adhesion machinery across evolutionary space and the role of focal adhesionsin vivoare largely understudied within the field. Furthering investigation in these areas is necessary to bolster our understanding of the role cell-substrate adhesion machinery across Eukaryotes plays during cell migration in physiological contexts such as cancer and pathogenesis. In this review, we review studies of cell-substrate adhesion machinery in organisms evolutionary distant from Metazoa and cover the current understanding and ongoing work on how focal adhesions function in single and collective cell migration in anin vivoenvironment, with an emphasis on work that directly visualizes cell-substrate adhesions. Finally, we discuss nuances that ought to be considered moving forward and the importance of future investigation in these emerging fields for application in other fields pertinent to adhesion-based processes.

1 February 2023 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
QXQian Xue
Qian Xue
SVSophia R.S. Varady
Sophia R.S. Varady
TWTrinity Q Alaka’i Waddell
Trinity Q Alaka’i Waddell
MRMackenzie R. Roman
Mackenzie R. Roman
JCJames Carrington
James Carrington
MRMinna Roh-Johnson
Minna Roh-Johnson
Focal adhesions are structures that physically link the cell to the extracellular matrix for cell migration. Although cell culture studies have provided a wealth of information regarding focal adhesion biology, it is critical to understand how focal adhesions are dynamically regulated in their native environment. We developed a zebrafish system to visualize focal adhesion structures during single-cell migration in vivo. We find that a key site of phosphoregulation (Y118) on Paxillin exhibits reduced phosphorylation in migrating cells in vivo compared to in vitro. Furthermore, expression of a non-phosphorylatable version of Y118-Paxillin increases focal adhesion disassembly and promotes cell migration in vivo, despite inhibiting cell migration in vitro. Using a mouse model, we further find that the upstream kinase, focal adhesion kinase, is downregulated in cells in vivo, and cells expressing non-phosphorylatable Y118-Paxillin exhibit increased activation of the CRKII-DOCK180/RacGEF pathway. Our findings provide significant new insight into the intrinsic regulation of focal adhesions in cells migrating in their native environment.

1 May 2019 in Developmental Cell
Verified
Journal Article
Closed access
QXQian Xue
Qian Xue
MRMinna Roh-Johnson
Minna Roh-Johnson